The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Pulmonx Corporation(NASDAQ:LUNG) 
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult p...
Website: http://www.pulmonx.com
Founded: 1995
Full Time Employees: 180
CEO: Glendon E. French
Sector: Other
Industry: Other
Pulmonx Number of Twitter Followers
Pulmonx Days Payable Outstanding ttm (DPO)
Pulmonx Days Receivable Outstanding ttm (DSO)
Pulmonx Days Inventory Outstanding ttm (DIO)
Pulmonx Op Cashflow Per Share ttm
Pulmonx Free Cashflow Per Share ttm
Pulmonx Cash Per Share ttm
Pulmonx P/S ratio ttm
Pulmonx (GAAP) P/E ratio ttm
Pulmonx P/B ratio ttm
No extra charts and metrics for this ticker.